Clinical biology of the pituitary adenoma

S Melmed, UB Kaiser, MB Lopes, J Bertherat… - Endocrine …, 2022 - academic.oup.com
All endocrine glands are susceptible to neoplastic growth, yet the health consequences of
these neoplasms differ between endocrine tissues. Pituitary neoplasms are highly prevalent …

Aggressive pituitary tumours and pituitary carcinomas

G Raverot, MD Ilie, H Lasolle, V Amodru… - Nature Reviews …, 2021 - nature.com
Although usually benign, anterior pituitary tumours occasionally exhibit aggressive
behaviour, with invasion of surrounding tissues, rapid growth, resistance to conventional …

[PDF][PDF] Pangenomic classification of pituitary neuroendocrine tumors

M Neou, C Villa, R Armignacco, A Jouinot… - Cancer cell, 2020 - cell.com
Pituitary neuroendocrine tumors (PitNETs) are common, with five main histological subtypes:
lactotroph, somatotroph, and thyrotroph (POU1F1/PIT1 lineage); corticotroph (TBX19/TPIT …

Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors

F Zhang, Q Zhang, J Zhu, B Yao, C Ma, N Qiao, S He… - Cell Research, 2022 - nature.com
Pituitary neuroendocrine tumor (PitNET) is one of the most common intracranial tumors. Due
to its extensive tumor heterogeneity and the lack of high-quality tissues for biomarker …

Novel insights into pituitary tumorigenesis: genetic and epigenetic mechanisms

V Srirangam Nadhamuni, M Korbonits - Endocrine reviews, 2020 - academic.oup.com
Substantial advances have been made recently in the pathobiology of pituitary tumors.
Similar to many other endocrine tumors, over the last few years we have recognized the role …

Marked response of a hypermutated ACTH-secreting pituitary carcinoma to ipilimumab and nivolumab

AL Lin, P Jonsson, V Tabar, TJ Yang… - The Journal of …, 2018 - academic.oup.com
Context Pituitary carcinoma is a rare and aggressive malignancy with a poor prognosis and
few effective treatment options. Case A 35-year-old woman presented with an aggressive …

The epigenomic landscape of pituitary adenomas reveals specific alterations and differentiates among acromegaly, Cushing's disease and endocrine-inactive …

MP Salomon, X Wang, DM Marzese, SC Hsu… - Clinical Cancer …, 2018 - AACR
Purpose: Pituitary adenomas are one of the most common benign neoplasms of the central
nervous system. Although emerging evidence suggests roles for both genetic and …

Identification of recurrent USP48 and BRAF mutations in Cushing's disease

J Chen, X Jian, S Deng, Z Ma, X Shou, Y Shen… - Nature …, 2018 - nature.com
Cushing's disease results from corticotroph adenomas of the pituitary that hypersecrete
adrenocorticotropin (ACTH), leading to excess glucocorticoid and hypercortisolism …

Driver mutations in USP8 wild-type Cushing's disease

S Sbiera, LG Perez-Rivas, L Taranets… - Neuro …, 2019 - academic.oup.com
Abstract Background Medical treatment in Cushing's disease (CD) is limited due to poor
understanding of its pathogenesis. Pathogenic variants of ubiquitin specific peptidase 8 …

The duality of human oncoproteins: drivers of cancer and congenital disorders

P Castel, KA Rauen, F McCormick - Nature Reviews Cancer, 2020 - nature.com
Human oncoproteins promote transformation of cells into tumours by dysregulating the
signalling pathways that are involved in cell growth, proliferation and death. Although …